128th MAINE LEGISLATURE
		LD 1600		LR 2346(02)
	An Act To Establish an Opioid Addiction Prevention and Rehabilitation Treatment Program Funded by a Tax Imposed upon the Sale of Opioids
	Fiscal Note for Bill as Amended by Committee Amendment " "
	Committee: Taxation
	Fiscal Note Required: Yes
Fiscal Note
			FY 2017-18	FY 2018-19	Projections  FY 2019-20	Projections  FY 2020-21
Net Cost (Savings)
	General Fund		$176,782	$78,981	$81,247	$83,580
Appropriations/Allocations
	General Fund		$176,782	$78,981	$81,247	$83,580
	Other Special Revenue Funds		$4,300,000	$6,500,000	$6,500,000	$6,500,000
Revenue
	General Fund		$0	$0	$0	$0
	Other Special Revenue Funds		$4,300,000	$6,500,000	$6,500,000	$6,500,000
Fiscal Detail and Notes
	The bill includes General Fund appropriations of $176,782 in fiscal year 2017-18 and $78,981 in fiscal year 2018-19 for one Tax Examiner position and related costs to process and administer an excise tax on manufacturers of opioids.  The appropriation in fiscal year 2017-18 includes one-time funding of $100,000 for programming costs to establish the new tax within the tax system.
	The bill includes Other Special Revenue Funds allocations to the Department of Health and Human Services of $4,300,000 in fiscal year 2017-18 and $6,500,000 in fiscal year 2018-19 for the Opioid Health Home Program with funding coming from the revenue received from the excise tax on manufacturers of opioids.
	Additional costs to the Department of Professional and Financial Regulation, Maine Board of Pharmacy, to annually identify opiods used in medication-assisted treatment and to notify the State Tax Assessor can be absorbed within existing budgeted resources.